Sequoia Financial Advisors LLC purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 74,814 shares of the real estate investment trust’s stock, valued at approximately $1,711,000.
Other hedge funds also recently added to or reduced their stakes in the company. Douglas Lane & Associates LLC purchased a new stake in shares of Healthpeak Properties in the third quarter worth about $33,947,000. Raymond James & Associates purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $25,711,000. Presima Securities ULC acquired a new position in Healthpeak Properties during the 3rd quarter worth approximately $22,465,000. AMF Tjanstepension AB purchased a new position in Healthpeak Properties in the 3rd quarter worth approximately $15,548,000. Finally, Handelsbanken Fonder AB acquired a new stake in Healthpeak Properties in the third quarter valued at approximately $11,668,000. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Stock Down 0.6 %
DOC stock opened at $22.99 on Friday. The firm has a fifty day moving average price of $22.24 and a two-hundred day moving average price of $20.64. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.70 and a quick ratio of 0.70. Healthpeak Properties, Inc. has a 1-year low of $15.24 and a 1-year high of $23.26. The firm has a market cap of $16.18 billion, a price-to-earnings ratio of 65.69, a PEG ratio of 2.27 and a beta of 1.14.
Analyst Ratings Changes
A number of research firms have recently commented on DOC. Wells Fargo & Company reissued an “equal weight” rating and set a $23.00 target price (up from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Wedbush boosted their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Scotiabank raised their target price on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research note on Monday, September 9th. Citigroup boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Finally, Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the company from $20.00 to $28.00 in a research note on Monday. One investment analyst has rated the stock with a sell rating, five have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.62.
Read Our Latest Stock Report on Healthpeak Properties
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also
- Five stocks we like better than Healthpeak Properties
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.